Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
30.16%
operating margin TTM
38.98%
revenue TTM
345.37 Million
revenue per share TTM
1.65$
valuation ratios | |
|---|---|
| pe ratio | 6.99 |
| peg ratio | 0.00 |
| price to book ratio | -15.48 |
| price to sales ratio | 2.10 |
| enterprise value multiple | 4.12 |
| price fair value | -15.48 |
profitability ratios | |
|---|---|
| gross profit margin | 97.74% |
| operating profit margin | 38.98% |
| pretax profit margin | 30.56% |
| net profit margin | 30.16% |
| return on assets | 51.32% |
| return on equity | -76.45% |
| return on capital employed | 107.2% |
liquidity ratios | |
|---|---|
| current ratio | 2.06 |
| quick ratio | 2.03 |
| cash ratio | 0.46 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 99.49 |
| operating cycle | 144.06 |
| days of payables outstanding | 291.68 |
| cash conversion cycle | -147.63 |
| receivables turnover | 8.19 |
| payables turnover | 1.25 |
| inventory turnover | 3.67 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.93 |
| debt equity ratio | -4.01 |
| long term debt to capitalization | 1.39 |
| total debt to capitalization | 1.33 |
| interest coverage | 4.32 |
| cash flow to debt ratio | 0.69 |
cash flow ratios | |
|---|---|
| free cash flow per share | 1.56 |
| cash per share | 1.30 |
| operating cash flow per share | 1.57 |
| free cash flow operating cash flow ratio | 0.99 |
| cash flow coverage ratios | 0.69 |
| short term coverage ratios | 8.26 |
| capital expenditure coverage ratio | 134.09 |
Frequently Asked Questions
When was the last time BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) reported earnings?
BioCryst Pharmaceuticals, Inc. (BCRX) published its most recent earnings results on 04-11-2025.
What is BioCryst Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)'s trailing twelve months ROE is -76.45%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. BioCryst Pharmaceuticals, Inc. (BCRX) currently has a ROA of 51.32%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did BCRX's net profit margin stand at?
BCRX reported a profit margin of 30.16% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is BCRX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.06 in the most recent quarter. The quick ratio stood at 2.03, with a Debt/Eq ratio of -4.01.